ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesJ91.0

J91.0

Malignant pleural effusion

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/06/2025

Code Description

ICD-10 J91.0 is a billable code used to indicate a diagnosis of malignant pleural effusion.

Key Diagnostic Point:

Malignant pleural effusion is characterized by the accumulation of fluid in the pleural space due to malignancy, often associated with lung cancer, breast cancer, or lymphoma. Clinically, patients may present with symptoms such as dyspnea, chest pain, and cough, which can significantly impair respiratory function. The pleura, a double-layered membrane surrounding the lungs, becomes compromised due to tumor invasion or obstruction of lymphatic drainage, leading to fluid buildup. Disease progression can vary, with some patients experiencing rapid deterioration while others may have a more chronic course. Diagnostic considerations include imaging studies such as chest X-rays or CT scans, which can reveal the presence of pleural effusion, and thoracentesis, which allows for fluid analysis to determine the etiology. Cytological examination of the pleural fluid is crucial for confirming malignancy. Early diagnosis and management are essential to alleviate symptoms and improve quality of life.

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Diagnostic complexity: Requires imaging and fluid analysis for accurate diagnosis.
  • Treatment complexity: Management may involve thoracentesis, pleurodesis, or chemotherapy.
  • Documentation requirements: Detailed clinical notes and imaging results are necessary.
  • Coding specificity: Requires precise coding to differentiate from other types of pleural effusion.

Audit Risk Factors

  • Common coding errors: Misclassification of effusion type or failure to document malignancy.
  • Documentation gaps: Incomplete clinical notes regarding symptoms or treatment.
  • Billing challenges: Potential denials if documentation does not support the diagnosis or treatment provided.

Specialty Focus

Medical Specialties

Pulmonology

Documentation Requirements

Standard ICD-10-CM documentation requirements apply

Common Clinical Scenarios

Various clinical presentations within this specialty area

Billing Considerations

Follow specialty-specific billing guidelines

Oncology

Documentation Requirements

Standard ICD-10-CM documentation requirements apply

Common Clinical Scenarios

Various clinical presentations within this specialty area

Billing Considerations

Follow specialty-specific billing guidelines

Related CPT Codes

CPT Code

Clinical Scenario

Documentation Requirements

CPT Code

Clinical Scenario

Documentation Requirements

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

Malignant pleural effusion significantly impacts patient quality of life and respiratory function, often leading to increased healthcare utilization due to frequent hospitalizations and procedures. It is a common complication in advanced malignancies, affecting a substantial portion of the cancer population. Understanding the epidemiology of malignant pleural effusion is crucial for developing effective management strategies and improving patient outcomes.

ICD-9 vs ICD-10

Malignant pleural effusion significantly impacts patient quality of life and respiratory function, often leading to increased healthcare utilization due to frequent hospitalizations and procedures. It is a common complication in advanced malignancies, affecting a substantial portion of the cancer population. Understanding the epidemiology of malignant pleural effusion is crucial for developing effective management strategies and improving patient outcomes.

Reimbursement & Billing Impact

Reimbursement considerations include the complexity of the procedure performed, such as thoracentesis or pleurodesis, and the necessity of follow-up care. Common denials may arise from insufficient documentation linking the diagnosis to the treatment provided. Best practices include ensuring that all clinical notes are thorough and that imaging and cytological results are readily available to support the coding.

Resources

Clinical References

  • •
    ICD-10 Official Guidelines for J00-J99
  • •
    Clinical Documentation Requirements

Coding & Billing References

  • •
    ICD-10 Official Guidelines for J00-J99
  • •
    Clinical Documentation Requirements

Frequently Asked Questions

What specific conditions are covered by J91.0?

J91.0 specifically covers pleural effusions that are attributable to malignant conditions, including but not limited to lung cancer, breast cancer, and lymphomas. It is essential to confirm the malignancy through cytological analysis of pleural fluid.

When should J91.0 be used instead of related codes?

J91.0 should be used when the pleural effusion is confirmed to be malignant. If the effusion is due to non-malignant causes, such as heart failure or infection, other codes like J90 should be selected.

What documentation supports J91.0?

Documentation should include clinical findings, imaging results, and cytological analysis of pleural fluid that confirms malignancy. Detailed notes on the patient's symptoms and treatment plan are also necessary.